Ultrahuman partners with Abu Dhabi to validate biological-age model
The smart ring maker signed a two-year MOU with local health authorities to develop a wearable-agnostic aging algorithm for national use.
Key points
- Ultrahuman and the Abu Dhabi Public Health Center signed a two-year agreement to develop and validate a biological-age estimation model.
- The system will combine clinical biomarkers with data from various wearable devices, including rings, wristbands, and patches.
- The startup aims to make the health-age estimates available to the broader UAE population through government digital-health platforms.
Ultrahuman, a Bengaluru-based health technology startup, announced on Monday that it has entered into a two-year memorandum of understanding with the Abu Dhabi Public Health Center (ADPHC). The partnership focuses on developing and clinically validating a biological-age model that the company intends to eventually roll out to residents across the United Arab Emirates.
The agreement allows Ultrahuman to combine clinical biomarkers with continuous data streams from wearable technology. According to the startup, this hybrid approach will help estimate how quickly an individual is aging and identify specific factors—such as sleep quality, physical activity, cardiovascular health, and metabolism—that may be accelerating or slowing that biological process.
Context and Background
This collaboration represents a strategic shift for Ultrahuman, which has historically been known primarily for its smart ring hardware. CEO Mohit Kumar told TechCrunch that the company views itself increasingly as a health-data organization rather than just a hardware vendor. He noted that while the smart ring serves as a primary method for acquiring physiological data, the core value lies in the algorithms that interpret that information to address aging, longevity, and other health metrics.
By partnering with a government entity, Ultrahuman aims to apply its health algorithms to a population far larger than its existing customer base. The startup has sold approximately 800,000 smart rings globally to date. However, the Abu Dhabi initiative marks its first step toward deploying a health algorithm at a national scale, moving beyond the proprietary ecosystem of its own device owners.
Who Is Affected
Although Ultrahuman is best known for its proprietary smart rings, Kumar emphasized that the biological-age model is being designed to be wearable-agnostic. This architecture allows data from a wide variety of devices—including rings, wrist-worn trackers, straps, and skin patches—to feed into the system alongside clinical biomarkers. This flexibility ensures that the model is not limited to users of a single brand of hardware.
Individuals in the UAE will eventually be able to access their health-age estimates through established government digital-health platforms, specifically TAMM and Sahatna. Ultrahuman and ADPHC will spend the next two years conducting research and clinical validation. Kumar stated that the broader rollout will occur in phases but did not provide a specific timeline for when the public could access the tool.
What should you do?
Security and technology professionals should monitor how health data from multiple wearable devices is aggregated and standardized in these government-led initiatives. The integration of clinical biomarkers with consumer device data raises questions about data interoperability and privacy safeguards. Organizations handling similar health-tech partnerships should review their data governance frameworks to ensure compliance with local regulations regarding sensitive physiological information.
What to do and how to stay safe: Ultrahuman
- Review data-sharing agreements to ensure clear definitions of ownership and usage rights for aggregated health data.
- Verify that wearable-agnostic platforms use encryption for data in transit and at rest across all connected device types.
- Monitor for updates on clinical validation standards to ensure the algorithms meet rigorous medical accuracy requirements.
- Assess the privacy implications of linking consumer wearable data with government health platforms like TAMM or Sahatna.
General security guidance from the Threat Times newsroom. It is not confirmed advice from the organisations named in this story.
Frequently asked questions
What is the goal of the partnership between Ultrahuman and Abu Dhabi?
The two-year partnership aims to develop and validate a biological-age model that combines clinical biomarkers with wearable device data for use across the UAE.
Will the biological-age model work with devices other than Ultrahuman rings?
Yes, the model is designed to be wearable-agnostic, accepting data from rings, wrist-worn devices, straps, and patches alongside clinical biomarkers.
When will the biological-age model be available to the public?
Ultrahuman and ADPHC will spend two years on research and validation, with a phased rollout planned, though no specific timeline was provided.
